Chronicled, the firm behind the blockchain-enabled pharmaceuticals traceability platform MediLedger, yesterday announced a collaboration with Deloitte to address issues in drug supply chains.
One of the chief problems the MediLedger solution addresses is counterfeit drugs, which can enter supply chains when pharmacies or hospitals return drugs to wholesalers. In the past, those counterfeit drugs have been inadvertently re-sold.
It seeks to remedy this by storing information about the drugs on a blockchain, which enables the returned drug to be compared to the original manufacturer’s data by scanning barcodes. In this vein, it responds to the USA’s Drug Supply Chain Security Act (DSCSA), which has several deadlines demanding improved traceability in drug supply chains.
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
